I read with interest the article by Cho and colleagues reporting the predictive qualities
of the S-LANSS (Self-completed Leeds Assessment of Neuropathic Symptoms and Signs)
neuropathic pain screening tool when used in patients with acute herpes zoster.
2
The authors report that no prior study has used screening tools in acute herpes zoster
patients with the aim of predicting the development of postherpetic neuralgia. However,
a DN4 (Douleur Neuropathique 4) screening tool diagnosis of neuropathic pain made
during the first 7 days of herpes zoster infection has also been shown to be an independent
predictor for the development of postherpetic neuralgia.
1
In addition, both the DN4 and LANSS screening tools demonstrate predictive qualities
when used in the acute setting for other conditions associated with the development
of chronic neuropathic pain, namely, following surgery.
3
,
4
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of PainAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practice.Pain. 2012; 153: 342-349
- Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: A single-center, 12-month, prospective cohort study.J Pain. 2014; 15: 149-156
- Risk factors predictive of chronic postsurgical neuropathic pain: The value of the iliac crest bone harvest model.Pain. 2012; 153: 1478-1483
- Can chronic neuropathic pain following thoracic surgery be predicted during the postoperative period?.Interact Cardiovasc Thorac Surg. 2009; 9: 999-1002
Article info
Footnotes
The author confirms no funding sources were provided, and no conflicts of interest exist.
Identification
Copyright
© 2014 American Pain Society. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Use of S-LANSS, a Tool for Screening Neuropathic Pain, for Predicting Postherpetic Neuralgia in Patients After Acute Herpes Zoster Events: A Single-Center, 12-Month, Prospective Cohort StudyThe Journal of PainVol. 15Issue 2
- PreviewPostherpetic neuralgia (PHN) is one of the most severe sequelae of herpes zoster events. Several risk factors have been reported for PHN, including old age, severe skin rash, and intense pain. This study therefore aims to evaluate the usefulness of the Self-completed Leeds Assessment of Neuropathic Symptoms and Signs pain scale (S-LANSS) in conjunction with previously reported risk factors for predicting PHN. A group of herpes zoster patients (N = 305) were included in the cohort study. Subjects were asked for their demographic information, clinical symptoms and signs, intensity of pain by visual analog scale (VAS), and S-LANSS.
- Full-Text
- Preview
- Response to Searle's Letter to the EditorThe Journal of PainVol. 15Issue 7
